Guanidinopropionic Acid
Chemical Structure and Physical Properties
Guanidinopropionic acid (GPA), formally identified by its IUPAC name 3-Carbamimidamidopropanoic acid or 3-(Diaminomethylideneamino)propanoic acid, is a biochemical compound with the molecular formula C4H9N3O2. It possesses a molar mass of 131.135 g/mol. In its pure form, it appears as odorless white crystals. The chemical architecture consists of a propionic acid chain substituted at the beta position (the 3-position) with a guanidino group. This dual functional nature—a basic guanidino group and an acidic carboxylic acid group—allows it to exist in various tautomeric and zwitterionic forms depending on physiological pH.
A critical physicochemical property of Guanidinopropionic acid is its partition coefficient (log P), which is recorded as -1.472. This highly negative log P value indicates that the molecule is extremely hydrophilic (water-soluble) and lipophobic. In a biological context, a log P of -1.472 suggests that GPA will not easily cross lipid bilayer membranes via passive diffusion. Instead, its absorption, cellular uptake, and systemic distribution likely rely on active transport mechanisms or facilitated diffusion via specific membrane transporters, potentially those that handle similar endogenous compounds like creatine or amino acids.
Neuromuscular and Systemic Implications of the Guanidine Moiety
While direct pharmacokinetic data on GPA is sparse, the pharmacological behavior of the guanidine moiety provides critical insights into its potential biological activity. Guanidine and its derivatives are known to interact significantly with the neuromuscular junction and systemic physiological processes. Formulations containing guanidine are associated with severe physiological alterations, including the risk of bleeding and infection. The mechanism behind these risks likely involves the suppression or alteration of hematopoietic pathways, leading to low blood cell counts. This manifests clinically as fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, and feeling light-headed or short of breath.
Furthermore, guanidine compounds can induce profound neurological and muscular effects. Documented side effects include numbness or tingling (paresthesia), particularly in the face, hands, or feet, as well as problems with balance or muscle movement, and tremors. These symptoms suggest that the guanidine structure interacts with voltage-gated ion channels or neurotransmitter receptors in both the central and peripheral nervous systems. Severe central nervous system (CNS) effects, such as confusion, hallucinations, and unusual thoughts or behavior, further underscore the ability of guanidine-based molecules to cross the blood-brain barrier or indirectly alter CNS neurochemistry.
Pharmacokinetic Interactions and Metabolic Pathways
The metabolic processing of guanidine-containing compounds is highly complex and prone to significant drug-drug interactions. Clinical data indicates that guanidine interacts with at least 89 different drugs, with 10 of these interactions classified as major.
One of the most critical interaction pathways involves hemostasis and coagulation. Guanidine interacts with Coumadin (warfarin) and Acetylsalicylic Acid (aspirin). Given that guanidine itself carries a warning for increased bleeding risk, co-administration with anticoagulants or antiplatelet agents likely results in a synergistic or additive pharmacodynamic effect, severely compromising the blood's ability to clot.
Additionally, guanidine interacts with metabolic and endocrine modulators, such as GlipiZIDE XL (glipizide) and Dexamethasone. The interaction with glipizide suggests that guanidine may influence glucose metabolism, insulin secretion, or insulin sensitivity, which aligns with its structural similarity to other metabolic regulators. The interaction with dexamethasone, a potent corticosteroid, could imply alterations in hepatic metabolism (potentially via Cytochrome P450 enzymes) or overlapping effects on immune suppression, given guanidine's known risk of increasing infection susceptibility.
Guanidine also shows interactions with a vast array of vitamins and minerals, including Vitamin A, B1 (thiamine), B2 (riboflavin), B6 (pyridoxine), B12 (cyanocobalamin), C (ascorbic acid), D2, D3, K, and Zinc. This broad spectrum of interactions suggests that guanidine may alter gastrointestinal absorption, compete for transport proteins, or interfere with the enzymatic pathways that utilize these micronutrients as cofactors. The interaction with Vitamin K is particularly notable, as it ties back to the coagulation cascade and the increased bleeding risks associated with guanidine use.
Is Gaa supplement safe? +
What is guanidinopropionic acid? +
What drugs should not be taken with prasugrel? +
What medications should not be taken with bupropion? +
What to avoid when taking betamethasone? +
What drugs should not be taken with depakote? +
What are the common side effects of guanidine? +
Can guanidine cause severe health issues? +
Does guanidine interact with aspirin? +
Can I take guanidine with warfarin? +
What is the IUPAC name for GPA? +
What is the chemical formula of Guanidinopropionic acid? +
What is the molar mass of GPA? +
Is Guanidinopropionic acid odorless? +
What does Guanidinopropionic acid look like? +
Does guanidine cause nerve issues? +
Can guanidine affect liver function? +
What are the signs of a severe allergic reaction to guanidine? +
Does guanidine interact with Ginkgo Biloba? +
Can guanidine be taken with Vitamin C? +
Everything About Guanidinopropionic Acid Article
Introduction to Guanidinopropionic Acid
Guanidinopropionic acid (GPA), also known by its IUPAC name 3-Carbamimidamidopropanoic acid, is a biochemical compound that has garnered interest in various research sectors. Often referred to as beta-guanidinopropionic acid, it is structurally characterized by a propionic acid backbone attached to a guanidino group. While it appears in select product catalogs, comprehensive clinical data regarding its efficacy as a dietary supplement remains elusive. Instead, the scientific community primarily views GPA through the lens of its chemical properties and the well-documented, potent pharmacological effects of its parent structure, guanidine.
Chemical Profile and Identification
Understanding the physical and chemical nature of Guanidinopropionic acid is crucial for researchers and formulators. The compound is identified by the CAS Registry Number 353-09-3 and the PubChem CID 67701. Its chemical formula is C4H9N3O2, yielding a molar mass of 131.135 g/mol. In its isolated form, GPA presents as odorless white crystals.
One of the most defining characteristics of GPA is its partition coefficient (log P), which is -1.472. In pharmacology, the log P value is a standard measure of a compound's lipophilicity. A negative value of this magnitude indicates that Guanidinopropionic acid is highly hydrophilic (water-soluble). Consequently, it is unlikely to cross lipid-rich biological membranes via simple passive diffusion. In the human body, compounds with such low log P values typically require specific transport proteins to enter cells, which heavily influences their bioavailability, half-life, and tissue distribution.
The Guanidine Connection: Systemic and Neuromuscular Effects
To understand the potential biological impact of Guanidinopropionic acid, one must examine the pharmacological profile of guanidine. Guanidine is a potent bioactive moiety that interacts with multiple systemic pathways. Medical literature warns that guanidine can cause serious health issues, particularly concerning the blood and immune systems.
Guanidine has been shown to increase the risk of bleeding and infection. It can induce a state of low blood cell counts, which manifests clinically through a variety of alarming symptoms: fever, chills, profound tiredness, mouth and skin sores, easy bruising, unusual bleeding, pale skin, cold extremities, and shortness of breath.
Furthermore, guanidine exerts significant effects on the nervous system and neuromuscular junctions. Users of guanidine-based medications have reported severe side effects including numbness or tingling (paresthesia) that is particularly pronounced in the face, hands, or feet. It can also cause problems with balance, muscle movement, and tremors. In severe cases, central nervous system toxicity can occur, leading to confusion, hallucinations, and unusual thoughts or behavior.
Safety, Side Effects, and Toxicity
The safety profile of guanidine compounds is fraught with potential adverse reactions. Beyond the severe hematological and neurological effects, common side effects include:
Gastrointestinal Distress: Nausea, diarrhea, stomach cramps, dry mouth, upset stomach, and loss of appetite. Dermatological Reactions: Sweating, rash, dry or scaly skin, flushing (a sudden warmth, redness, or tingly feeling), and redness or crusting around hair follicles. Psychological Effects: Feeling nervous or irritable. Hepatic Stress: Abnormal liver function tests, indicating potential hepatotoxicity. Renal/Urinary Issues: Painful urination, or the presence of blood or pus in the urine. Cardiovascular Symptoms: Fast or pounding heartbeats, and light-headedness akin to fainting.
Any individual experiencing signs of an allergic reaction—such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat—should seek emergency medical help immediately.
Major Drug Interactions
The metabolic and pharmacodynamic complexity of guanidine is highlighted by its extensive list of drug interactions. Clinical databases track at least 89 known drugs that interact with guanidine, 10 of which are classified as major interactions.
Anticoagulants and Antiplatelets Guanidine exhibits major interactions with Coumadin (warfarin) and Acetylsalicylic Acid (aspirin). Because guanidine independently increases the risk of bleeding, combining it with blood thinners creates a dangerous synergistic effect that can lead to severe, uncontrolled hemorrhage.
Metabolic and Endocrine Medications Interactions with GlipiZIDE XL (a diabetes medication) and Dexamethasone Intensol (a corticosteroid) suggest that guanidine compounds can interfere with glucose metabolism and immune regulation.
Vitamins and Supplements Surprisingly, guanidine interacts with a vast array of common vitamins and supplements. This includes Ginkgo Biloba, L-Arginine, Saccharomyces Boulardii, Zinc, and Vitamins A, B1, B2, B6, B12, C, D2, D3, and K. The interaction with Vitamin K is particularly concerning given Vitamin K's role in blood clotting. These broad interactions imply that guanidine may disrupt gastrointestinal absorption or compete for vital metabolic enzymes.
Other Notable Interactions Guanidine also interacts with Morphine Sulfate, Paracetamol (acetaminophen), Penicillin G Procaine, Epogen (epoetin alfa), and various high and low molecular weight Dextrans.
Sourcing and Analytical Standards
For research purposes, 3-Guanidinopropionic Acid is synthesized and distributed by specialized biochemical suppliers, such as Cayman Chemical. It is utilized in laboratory settings for bioanalysis, assay development, and medicinal chemistry. Due to the lack of established dietary supplement guidelines and the severe risk profile of the guanidine moiety, its use remains strictly within the purview of controlled scientific research and specialized medical applications.